PYRAZOLOPYRIMIDINE PDE9 INHIBITORS
개요
발명자
Ashok ARASAPPAN; Jason M. COX; John S. DEBENHAM; Zhe FENG; Zhuyan GUO; Dongfang MENG
IPC 분류
CPC 분류
The present invention is directed to amino and alkyl pyrazolopyrimidine compounds which may be useful as therapeutic agents for the treatment of disorders associated with phosphodiesterase 9 (PDE9). The present invention also relates to the use of such compounds for treating cardiovascular and cerebrovascular diseases, such as hypertension, chronic kidney disease and heart failure, and neurological and psychiatric disorders, such as schizophrenia, psychosis or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction.
원문 (중국어)
The present invention is directed to amino and alkyl pyrazolopyrimidine compounds which may be useful as therapeutic agents for the treatment of disorders associated with phosphodiesterase 9 (PDE9). The present invention also relates to the use of such compounds for treating cardiovascular and cerebrovascular diseases, such as hypertension, chronic kidney disease and heart failure, and neurological and psychiatric disorders, such as schizophrenia, psychosis or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction.
로그인하고 전문 읽기
청구항 1을 표시했습니다. 무료 가입하면 전체 12개 청구항, 명세서 전문, 전체 도면, 번역, 법적 상태를 볼 수 있습니다.
- 전체 청구항